Cambrex Corporation (NYSE:CBM)

Monday, February 14, 2011 | Web News
On February 11, 2011 we initiated a short-term trading position in shares of CBM @ 6.30 The company reported 2010 fourth quarter EPS of...
See All Research...

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients ("APIs"), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.

Web site: http://www.cambrex.com.

Last updated July 30, 2008